A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea

Jocelyn Y. Cheng, Daniel Lorch, Alan D. Lowe, Naohisa Uchimura, Nancy Hall, Dhara Shah, Margaret Moline

Open source

DOI
10.5664/jcsm.10788
Published
2024-01
Container
Journal of Clinical Sleep Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5664/jcsm.10788,
  title = {A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea},
  author = {Jocelyn Y. Cheng and Daniel Lorch and Alan D. Lowe and Naohisa Uchimura and Nancy Hall and Dhara Shah and Margaret Moline},
  year = {2024},
  journal = {Journal of Clinical Sleep Medicine},
  doi = {10.5664/jcsm.10788},
  url = {https://doi.org/10.5664/jcsm.10788}
}

RIS

TY  - JOUR
TI  - A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea
AU  - Jocelyn Y. Cheng
AU  - Daniel Lorch
AU  - Alan D. Lowe
AU  - Naohisa Uchimura
AU  - Nancy Hall
AU  - Dhara Shah
AU  - Margaret Moline
PY  - 2024
JO  - Journal of Clinical Sleep Medicine
DO  - 10.5664/jcsm.10788
UR  - https://doi.org/10.5664/jcsm.10788
ER  - 

APA

Cheng, J. Y., Lorch, D., Lowe, A. D., Uchimura, N., Hall, N., Shah, D., & Moline, M. (2024). A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.10788

Source records